Page last updated: 2024-08-24

nelfinavir and molnupiravir

nelfinavir has been researched along with molnupiravir in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bakowski, MA; Beutler, N; Burton, DR; Chatterjee, AK; Chen, E; Chi, V; Das, S; Fuller, M; Garcia, E; Ghosh, P; Gupta, AK; Huang, E; Hull, MV; Joseph, SB; Kirkpatrick, MG; Kuo, P; McNamara, CW; Nguyen, TH; Pan, K; Parren, M; Ricketts, J; Riva, L; Roberts, AJ; Rogers, TF; Sahoo, D; Schultz, PG; Shaabani, N; Teijaro, JR; Vargas, N; Wolff, KC; Woods, AK; Yang, L	1

Other Studies

1 other study(ies) available for nelfinavir and molnupiravir

Article	Year
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions. Nature communications, 2021, 06-03, Volume: 12, Issue:1 Topics: Animals; Antiviral Agents; Cell Line; COVID-19; COVID-19 Drug Treatment; Cytidine; Databases, Pharmaceutical; Drug Discovery; Drug Evaluation, Preclinical; Drug Repositioning; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxylamines; Mesocricetus; Nelfinavir; Pandemics; SARS-CoV-2; Virus Replication	2021

Article

Year

Drug repurposing screens identify chemical entities for the development of COVID-19 interventions.

Nature communications, 2021, 06-03, Volume: 12, Issue:1

Topics: Animals; Antiviral Agents; Cell Line; COVID-19; COVID-19 Drug Treatment; Cytidine; Databases, Pharmaceutical; Drug Discovery; Drug Evaluation, Preclinical; Drug Repositioning; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxylamines; Mesocricetus; Nelfinavir; Pandemics; SARS-CoV-2; Virus Replication

2021